- Home
- STFS vs CING Comparison
STFS vs CING Comparison
Compare STFS & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STFS
- CING
- Stock Information
- Founded
- STFS 2015
- CING 2012
- Country
- STFS China
- CING United States
- Employees
- STFS N/A
- CING N/A
- Industry
- STFS
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- STFS
- CING Health Care
- Exchange
- STFS NYSE
- CING Nasdaq
- Market Cap
- STFS 11.9M
- CING 15.3M
- IPO Year
- STFS 2024
- CING 2021
- Fundamental
- Price
- STFS $1.16
- CING $4.30
- Analyst Decision
- STFS
- CING Strong Buy
- Analyst Count
- STFS 0
- CING 4
- Target Price
- STFS N/A
- CING $30.67
- AVG Volume (30 Days)
- STFS 186.4K
- CING 94.3K
- Earning Date
- STFS 02-14-2025
- CING 05-07-2025
- Dividend Yield
- STFS N/A
- CING N/A
- EPS Growth
- STFS 43.38
- CING N/A
- EPS
- STFS 0.15
- CING N/A
- Revenue
- STFS $14,972,726.00
- CING N/A
- Revenue This Year
- STFS N/A
- CING N/A
- Revenue Next Year
- STFS N/A
- CING N/A
- P/E Ratio
- STFS $7.52
- CING N/A
- Revenue Growth
- STFS 57.60
- CING N/A
- 52 Week Low
- STFS $0.80
- CING $1.80
- 52 Week High
- STFS $17.91
- CING $20.83
- Technical
- Relative Strength Index (RSI)
- STFS N/A
- CING 57.30
- Support Level
- STFS N/A
- CING $4.03
- Resistance Level
- STFS N/A
- CING $4.44
- Average True Range (ATR)
- STFS 0.00
- CING 0.29
- MACD
- STFS 0.00
- CING 0.05
- Stochastic Oscillator
- STFS 0.00
- CING 74.38
About STFS STAR FASHION CULTURE HOLDINGS LIMITED
Star Fashion Culture Holdings Ltd is a content marketing solutions services provider. The company offer services focusing on marketing campaign planning and execution, offline advertising services; and online precision marketing services. The services also include marketing campaign planning and execution, events including marathons, sports events, and music festivals.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.